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Abstract: Background: Accurate awareness of common disease risk is necessary to
promote healthy lifestyles and to prevent unnecessary anxiety and evaluation. Our
objective is to identify characteristics of patients who do not accurately perceive
their risk of developing coronary heart disease (CHD), diabetes (DM), breast cancer
(BC) and colorectal cancer (CRC). Methods: Using personalized disease risk reports
and risk perception surveys, subjects (n = 4703) were classified as high or low/average risk and high or low/average perceived risk for each condition. Models were used
to examine factors associated with risk under-estimation by high risk patients and
risk over-estimation by low/average risk patients. Results: Patients at high risk for
DM, BC and CRC often (60–75% of the time) under-estimated their risk, while low/
average risk patients overestimated their risk 13–40% of the time. For CHD, underestimation by high risk individuals approximated over-estimation by low/average
individuals. Compared to normal weight patients at high risk for cancer, obese
patients were more likely to under-estimate their risk for BC (OR 3.1, CI 1.9–5.0) and
CRC (2.6, 1.5–4.5) as were overweight patients. Overweight and obese patients at
low/average risk of DM or CHD were more likely than normal weight patients to overestimate their risk. Low/average risk women were more likely than men to overestimate their risk of DM (1.3, 1.1–1.5) and CHD (1.8, 1.5–2.1). Conclusions: Our data
show that body mass index is the factor most consistently associated with incorrect
risk perceptions for several common conditions.
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Accurate understanding of a person’s risk of
developing common diseases, like heart disease,
diabetes, breast and colon cancer, is needed to
encourage healthy lifestyle behaviors and to
prevent unnecessary anxiety and evaluation. This
study compares a person’s beliefs about their risk
of developing these common diseases to their
risk estimated from their characteristics and risk
factors. We find that it is common (60 to 75%
of the time) for high risk individuals to underestimate their risk, while low/average risk patients
overestimate their risk 13–40% of the time.
Accurate risk estimation varies by gender, and
body mass index is associated with incorrect risk
perceptions for several common conditions.

© 2018 The Author(s). This open access article is distributed under a Creative Commons Attribution
(CC-BY) 4.0 license.
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1. Introduction
Non-communicable diseases such as cardiovascular diseases, diabetes, and cancer, are the leading
cause of death globally, and are the main drivers of morbidity, and health-care costs in the US
(Bauer, Briss, Goodman, & Bowman, 2014). Patients’ perception of their actual risk of disease or the
belief in the probability that they will experience an adverse event is important regardless of actual
risk for developing these diseases (Lavielle & Wacher, 2014; Leite-Pereira, Medeiros, & Dinis-Ribeiro,
2011). For those at high risk, an accurate understanding of risk can help patients identify and adopt
relevant lifestyle changes and adherence to preventive interventions (e.g. early or more intensive
screening, pharmacologic treatment, prophylactic surgery) that can lead to a better health-related
quality of life (Cainzos-Achirica & Blaha, 2015; Dieng et al., 2014; Fagan, Sifri, Wender, Schumacher,
& Reed, 2012; Leite-Pereira et al., 2011; Wang et al., 2009). For those at low or average risk, accurate
risk perception can help patients reduce anxiety and avoid unnecessary intervention (Haas et al.,
2005).
Previous research has shown that patients overall and individuals both at high or low/ average risk
for these diseases do not correctly perceive their risk (Cainzos-Achirica & Blaha, 2015; Everett,
Salamonson, Rolley, & Davidson, 2016; Fagan et al., 2012; Leite-Pereira et al., 2011; van der Weijden,
Bos, & Koelewijn-van Loon, 2008; Wang et al., 2009). For example, overweight and obese patients
may not perceive they are at higher risk for colorectal cancer (CRC);(Fagan et al., 2012) patients at
high risk for diabetes (DM) or heart disease (CHD) are often not aware of this risk; (Adriaanse et al.,
2008; Darlow, Goodman, Stafford, Lachance, & Kaphingst, 2012) many women both over–estimate
or under-estimate their risk of breast cancer BC) (de Jonge, Vlasselaer, Van de Putte, & Schobbens,
2009; Erblich, Bovbjerg, Norman, Valdimarsdottir, & Montgomery, 2000; Haas et al., 2005). Prior work
has focused on examining risk perceptions for specific conditions. We are not aware of prior studies
that have looked at risk perceptions across cancers and other common conditions, stratified by patients’ actual risk of these diseases.
The goal of this analysis is to identify demographic characteristics of patients at low/ average risk
who over-estimate their risk and those at high risk who under-estimate their risks of CHD, DM, BC and
CRC.

2. Methods
2.1. Overview
The Patient Risk Evaluation and Prevention (PREP) study was a cluster randomized controlled trial
(RCT) of adult primary care patients receiving care in the Brigham and Women’s Primary Care
Practice-Based Research Network (NCT01468675) (Haas et al., 2017). A goal of PREP was to assess
whether patients’ receipt of a personalized disease risk report prior to a primary care visit was associated with improved patient-provider communication about disease risk. Patients in intervention
clinics completed a detailed survey about their family history, lifestyle, and risk perceptions and received a personalized risk report based on Your Health Snapshot (YHS), a self-administered health
risk assessment derived from validated algorithms of Your Disease Risk (www.yourdiseaserisk.wustl.
edu) (Colditz et al., 2000; Kim, Rockhill, & Colditz, 2004). Risk factors inputs for the algorithms were
obtained from the survey responses and data from the electronic health record (EHR) prior to the
visit. Patients in the control clinics completed a short survey about risk perceptions before their visit.
After their visit, they completed the detailed survey and received a personal risk report. Risk reports
presented calculated risk, summarized as low or average vs. high risk, for CHD, DM, CRC and BC
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(women only) for patients who did not already have a specific condition (Colditz et al., 2000; Kim,
Rockhill, & Colditz, 2004). For example, a woman who had already been diagnosed with CHD would
not be asked about her risk of developing CHD, but would be asked about her risk for the other 3
conditions. Risk perception questions asked separately for each condition whether compared to an
average person of the same age, an individual believed that he/ she was more likely, less likely or
about as likely to get the condition (“Compared to the average person your age, would you say that
you are more likely to get {condition}, less likely, or about as likely?”) We conducted a secondary
analysis of data collected from PREP to identify demographic characteristics of patients who do not
accurately perceive their risk of developing CHD, DM, BC and CRC, so that appropriate interventions
can be developed.

2.2. Data analysis
We included participants, irrespective of intervention status, who answered the pre-visit risk perception questions and received a risk report (intervention arm received pre-visit, control arm received
post-visit). For the purposes of this analysis, we combined low or average calculated and perceived
risk into a category of low/average risk (i.e. not high). Among those categorized as low/average calculated risk, the percent that was low risk compared to average risk was 88% for DM, 93% for CHD,
50% for BC and 59% for CRC. Additional patient data, obtained from the EHR, included age, sex, race,
education, ethnicity, marital status, insurance, body mass index (BMI), smoking status, prior personal history of CHD, DM, BC or CRC and Charlson comorbidity score (Charlson, Pompei, Ales, &
MacKenzie, 1987). For each of the conditions, we used logistic regression models to examine the
demographic factors associated with high risk patients who under-estimated their risk and low/average risk patients who over-estimated their risk. Statistical analyses were conducted using SAS
version 9.2 (Cary, NC) with p < 0.05 as the criterion for statistical significance.

3. Results
3.1. Study population
Overall, the mean age of participants was 54 years, 75.5% were female, 5.8% were Latino, and 5.1%
were black (Table 1). Almost 26% of participants were obese and 3.5% were current smokers.
Approximately 70% had college or higher education degrees and 74% had private insurance. Fifteen
percent were at high risk for developing CRC, 19.5% for breast cancer, 16.8% for DM, and 6.7% for
CHD.
Among patients at low/average risk for disease, the percentage who over-estimated their perceived risk of disease, ranged from 13% for CRC to 56% for CHD (Table 2). Women were more likely
than men to overestimate their risk of diabetes (1.3, 1.1–1.5) and CHD (1.8, 1.5–2.1). Compared to
normal weight patients (BMI 18.5–24.9 kg/m2), overweight patients (BMI 25–29.9) were more likely
to overestimate their risk of DM (1.6, 1.3–1.8) and CHD (1.5, 1.3–1.8), but less likely to overestimate
their risk of BC (0.6, 0.5–0.8) and CRC (0.9, 0.7–1.0). The same was true for obese patients (BMI ≥ 30).
Compared to whites, blacks were also more likely to over-estimate their risk for DM and less likely to
overestimate their risk for CRC. Patients age 45–75 were less likely to over-estimate risk of DM and
BC compared to younger patients.
Among patients at high risk for disease, self-perceived under-estimation ranged from 57% for CHD
to 75% for CRC (Table 3). Overweight and obese patients were more likely than normal weight patients to under-estimate their risk for BC (1.7, 1.1–2.8; 3.1, 1.9–5.0 respectively) and to under-estimate their risk for CRC (1.8, 1.0–3.3; 2.6, 1.5–4.5, respectively). Compared to whites, Hispanics were
less likely to underestimate their risk for diabetes (0.4, 0.2–0.8).
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Table 1. Characteristics of participants
N (%)
Overall N = 4,703
Age in years, mean (SD)

53.6 (11.8)

Sex
Female

3,549 (75.5)

Race/ethnicity
White

39.59 (84.2)

Black

238 (5.1)

Latino

271 (5.8)

Other/unknown

235 (5.0)

Marital status
Married or living with partner

3,234 (68.8)

Insurance
Private

3,460 (73.6)

Medicare

937 (19.9)

Medicaid

306 (6.5)

BMI category
Normal/underweight

1,866 (39.7)

Overweight

1,627 (34.6)

Obese

1,206 (25.6)

Smoking status
Current

163 (3.5)

Former

1,556 (33.2)

Never

2,971 (63.3)

Education
College graduate or higher

3,273(69.6)

Some college

614 (13.1)

High school graduate or less

431 (9.2)

Other/don’t know

385 (8.2)

Prior personal history of
Colon cancer

51 (1.1)

Breast cancer (women only)

268 (7.6)

Diabetes

349 (7.4)

CHD

334 (7.1)

Mean Charlson comorbidity score (range)
0

4,234 (90.0)

1

275 (5.9)

2,3

194 (4.1)

High risk for developing1
Colon cancer

645 (14.9)

Breast cancer (women only)

597 (19.5)

Diabetes

680 (16.8)

CHD

270 (6.7)

1

The denominator includes those subjects who had both a risk report and answer to the risk perception question. The

denominators are: 4,339 for colon cancer, 3,055 for breast cancer, 4,041 for diabetes and 4,037 for CHD. Percentages
may not add to 100% because of rounding.
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Table 2. Patients with low/average risk who over-estimate risk by disease
Diabetes1
No. (%)
Overall

CHD1

OR (CI)

1,304 (38.8)

No. (%)

Breast cancer (Female
only) 2
OR (CI)

2,093 (55.6)

No. (%)

OR (CI)

788 (32.1)

Colon cancer1
No. (%)

OR (CI)

1,482 (13.0)

Age (years)
30–44

334 (42.8)

reference

518 (57.0)

reference

283 (42.8)

reference

365 (42.9)

reference

45–59

566 (40.1)

0.8 (0.7–1.0)

922 (57.3)

1.0 (0.8–1.2)

346 (33.1)

0.6 (0.5–0.8)

623 (41.2)

0.9 (0.8–1.1)

60–75

404 (34.5)

0.7 (0.6–0.9)

653 (52.2)

0.9 (0.7–1.1)

159 (21.2)

0.3 (0.2–0.4)

494 (37.1)

0.9 (0.7–1.1)

p value χ2

0.0004

0.0157

<.0001

0.0136

Sex
Female

997 (39.5)

1.3 (1.1–1.5)

1713 (58.0)

1.8 (1.5–2.1)

1134 (41.1)

1.1 (0.9–1.3)

Male

307 (36.6)

reference

380 (46.7)

reference

348 (37.1)

reference

p value χ2

0.1340

<.0001

0.0313

BMI
Normal/
underweight

585 (34.8)

reference

826 (50.0)

reference

485 (40.1)

reference

763 (46.6)

reference

Overweight

582 (43.8)

1.6 (1.3–1.8)

769 (57.7)

1.5 (1.3–1.8)

215 (29.9)

0.6 (0.5–0.8)

581 (41.8)

0.9 (0.7–1.0)

Obese

137 (38.7)

1.2 (1.0–1.6)

498 (63.7)

1.8 (1.5–2.2)

88 (16.6)

0.3 (0.2–0.4)

138 (20.8)

0.3 (0.3–0.4)

p value χ2

<.0001

<.0001

<.0001

<.0001

Race
White

1,126 (37.9)

reference

1,805 (55.4)

reference

652 (32.0)

reference

1,315 (41.1)

reference

Black

47 (49.5)

1.5 (1.0–2.2)

82 (56.6)

0.9 (0.6–1.3)

30 (23.4)

0.8 (0.5–1.3)

38 (27.1)

0.7 (0.5–1.0)

Hispanic

48 (42.9)

1.0 (0.6–1.5)

100 (59.2)

1.2 (0.9–1.7)

54 (34.8)

1.1 (0.7–1.6)

54 (33.5)

0.9 (0.6–1.3)

Other/DK

83 (45.6)

1.4 (1.0–1.9)

106 (54.1)

1.0 (0.7–1.3)

52 (37.7)

1.0 (0.7–1.5)

75 (39.5)

0.8 (0.6–1.1)

p value χ2

0.0187

0.7634

0.0744

0.0030

Insurance
1,031 (39.6)

reference

1,670 (57.1)

reference

642 (34.0)

reference

1,171 (41.9)

reference

Medicare

200 (33.4)

0.9 (0.7–1.2)

322 (51.0)

0.8 (0.7–1.0)

90 (22.9)

1.1 (0.8–1.5)

248 (35.2)

0.9 (0.7–1.1)

Medicaid

73 (44.8)

1.2 (0.8–1.7)

101 (48.1)

0.6 (0.4–0.8)

56 (32.2)

0.9 (0.6–1.3)

63 (32.0)

0.8 (0.6–1.1)

p value χ2

0.0049

Private

0.0018

0.0001

0.0003

Education
HS grad or less

87 (44.2)

1.2 (0.9–1.7)

144 (56.0)

1.0 (0.7–1.3)

67 (30.9)

1.4 (1.0–2.0)

89 (33.0)

0.9 (0.7–1.2)

Some college

149 (38.4)

1.0 (0.8–1.3)

268 (59.2)

1.1 (0.9–1.3)

109 (31.7)

1.3 (1.0–1.6)

166 (37.9)

1.0 (0.8–1.2)

College grad or
higher

958 (38.2)

reference

1,514 (55.1)

reference

543 (32.1)

reference

1,110 (41.4)

reference

Other/DK

110 (40.3)

1.0 (0.8–1.3)

167 (53.4)

0.9 (0.7–1.2)

69 (34.0)

1.2 (0.9–1.7)

117 (38.2)

0.9 (0.7–1.2)

p value χ

0.3925

2

0.3617

0.9169

0.0295

Models adjusted for education, smoking status, BMI, sex, race/ethnicity, insurance, age, marital status, Charlson category and group (intervention or control).

1

Model adjusted for all variables listed above except sex.

2

4. Discussion
Accurate awareness of common disease risk in both high and low/average risk persons is an important factor in promoting positive lifestyle and behaviors and preventing unnecessary interventions,
anxiety and screenings. To our knowledge, ours is the first study to compare risk perceptions of patients, stratified by risk, to actual risk across several common conditions. We found that overall, except for CHD where approximately 55% of both high and low risk patients incorrectly estimated risk,
high risk patients often (60 to 75% of the time) under-estimated their risk, while low/average risk
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Table 3. Patients with high risk patients who under-estimate risk by disease
Diabetes1
No. (%)
Overall

OR (CI)

409 (60.1)

CHD1
No. (%)

Breast cancer (Female
only)2
OR (CI)

155 (57.4)

No. (%)

OR (CI)

433 (72.5)

Colon cancer1
No. (%)

OR (CI)

481 (74.6)

Age (years)
30–44

82 (52.9)

reference

22 (53.7)

reference

73 (67.6)

reference

99 (81.8)

reference

45–59

160 (55.6)

1.0 (0.7–1.5)

62 (53.5)

1.2 (0.6–2.5)

177 (70.0)

1.2 (0.7–2.1)

213 (74.2)

0.7 (0.4–1.2)

60–75

167 (70.5)

1.7 (1.0–2.8)

71 (62.8)

1.3 (0.6–3.1)

183 (77.9)

1.4 (0.8–2.5)

169 (71.3)

0.7 (0.4–1.2)

p value χ2

0.0003

0.3105

0.0573

0.0953

Sex
Female

311 (58.0)

0.7 (0.4–1.0)

84 (53.9)

0.7 (0.4–1.3)

366 (74.0)

0.8 (0.5–1.3)

Male

98 (68.1)

reference

71 (62.3)

reference

115 (76.1)

reference

p value χ2

0.0290

0.1663

0.6092

BMI
Normal/
underweight

12 (80.0)

reference

7 (70)

reference

111 (61.3)

reference

48 (59.3)

reference

Overweight

71 (71.7)

0.6 (0.1–2.3)

31 (56.4)

0.5 (0.1–2.5)

138 (72.3)

1.7 (1.1–2.8)

89 (70.1)

1.8 (1.0–3.3)

Obese

326 (57.6)

0.3 (0.1–1.0)

117 (57.1)

0.5 (0.1–2.3)

184 (81.8)

3.1 (1.9–5.0)

344 (78.7)

2.6 (1.5–4.5)

p value χ2

.0085

0.7109

<.0001

0.0005

Race
White

327 (62.6)

reference

116 (56.3)

reference

396 (73.6)

reference

373 (73.1)

reference

Black

33 (52.4)

0.7 (0.4–1.2)

15 (57.7)

1.3 (0.5–3.1)

16 (72.7)

0.7 (0.3–2.1)

47 (85.5)

1.9 (0.8–4.3)

Hispanic

34 (46.6)

0.4 (0.2–0.8)

20 (64.5)

2.1 (0.8–5.3)

11 (61.1)

0.6 (0.2–1.9)

41 (75.9)

1.1 (0.5–2.3)

Other/DK

15 (68.2)

1.0 (0.4–2.6)

4 (57.1)

1.4 (0.3–7.1)

10 (52.6)

0.5 (0.2–1.4)

20 (76.9)

1.4 (0.5–3.9)

p value χ2

0.0274

0.8630

0.1533

0.2491

Insurance
Private

275 (57.8)

reference

94 (53.7)

reference

311 (70.5)

reference

338 (76.6)

reference

Medicare

99 (70.2)

1.4 (0.8–2.2)

46 (67.7)

2.0 (1.0–4.2)

108 (81.2)

1.6 (0.8–2.9)

99 (69.7)

0.7 (0.4–1.1)

Medicaid

35 (55.5)

1.3 (0.7–2.4)

15 (55.6)

1.0 (0.4–2.6)

14 (60.9)

0.7 (0.2–1.9)

44 (71.0)

0.5 (0.3–1.1)

p value χ2

0.0220

0.1402

0.0237

0.2032

Education
HS grad or less

59 (61.5)

1.4 (0.8–2.3)

28 (56.0)

0.9 (0.4–1.8)

28 (73.7)

1.2 (0.5–3.1)

69 (79.3)

1.3 (0.7–2.5)

Some college

74 (58.7)

1.3 (0.8–2.0)

27 (52.9)

0.7 (0.3–1.4)

60 (74.1)

1.0 (0.6–1.8)

93 (75.0)

1.1 (0.7–1.8)

College grad or
higher

233 (58.5)

reference

89 (61.8)

reference

311 (72.7)

reference

283 (73.7)

reference

Other/DK

43 (71.7)

2.1 (1.1–4.0)

11 (44.0)

0.5 (0.2–1.4)

34 (68.0)

1.0 (0.5–1.9)

36 (72)

1.0 (0.5–2.1)

p value χ

0.2699

2

0.3295

0.8870

0.7123

Models adjusted for education, smoking status, BMI, sex, race/ethnicity, insurance, age, marital status, Charlson category and group (intervention or control).

1

Model adjusted for all variables listed above except sex.

2

patients overestimated their risk of these conditions 13–40% of the time. We found BMI to be the
demographic factor most consistently associated with incorrect risk perceptions. Patients who were
overweight or obese, and who were at high risk for BC or CRC were more likely to under-estimate
their risks of these cancers. Although obesity has been shown to be a risk factor for CRC and for BC
among post-menopausal women (Bhaskaran et al., 2014; Leite-Pereira et al., 2011; Renehan &
Soerjomataram, 2016), studies have also shown that knowledge of obesity as a risk factor for cancer,
including CRC and BC, is low (Consedine, Magai, Conway, & Neugut, 2004; Fagan et al., 2012;
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Leite-Pereira et al., 2011). In particular, a previous study found that even with the understanding
that behavioral factors can reduce cancer risk, many subjects, including those who were obese, did
not consider overweight as an important risk factor for cancer (Cameron et al., 2010). Further, weight
perceptions can be inaccurate (Squiers et al., 2014). Given the high prevalence of obesity in the US
(Ogden, Carroll, Fryar, & Flegal, 2015), these results underscore the need for health education programs targeted to overweight and obese persons which stress weight as a modifiable cancer risk
and the importance of appropriate cancer screenings. In addition, studies are needed determine
how such education programs can be most effective.
We also found that overweight and obese patients at low/average risk for CHD and DM were more
likely to over-estimate their risks of these diseases. This finding is consistent with prior studies which
found obese people in general over-estimate DM, CHD risks (Darlow et al., 2012; van der Weijden et
al., 2008; Winter & Wuppermann, 2014), and suggests an understanding of weight as a significant
risk factor for these diseases, even if other risk factors are not present. However, a disadvantage of
over-estimation can be over-prescription of medications where harms may outweigh benefits. In
addition, we note that although heightened risk perception may lead to an increase in preventive
behavior, studies have also shown that awareness alone does not motivate behavior (Alzaman,
Wartak, Friderici, & Rothberg, 2013; Lavielle & Wacher, 2014).
A limitation of this study is that PREP only reached 20% of potentially eligible individuals; most of
our population was white and of higher socioeconomic status. It is possible that individuals who
participated are more “health conscious,” as indicated by our low percentage of current smokers.
Therefore, our study may include fewer high risk individuals compared to the general population of
patients seen in primary care settings. However, we are not comparing low risk to high risk individuals, and our sample size is robust for both high risk and low risk patients across the demographic
factors.
In conclusion, for those at high risk of developing BC, CRC, CHD or DM overall and for overweight
and obese individuals who are both at high and low risk of disease, perceived risk estimates are often
inaccurate. Primary care doctors should be aware that their patients’ perceived risks may not necessarily correspond to actual risks. Public health education should focus on correcting perceptions of
disease risk, and further research is needed to determine the most appropriate education and
whether correct perceptions lead to improved behavioral and health outcomes.
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Appendix A. Consort diagram

31,223 Patients Randomized and Contacted
14,843 Potentially Eligible Intervention Patients
(47.5%)
508 Ineligible at
Contact for PreVisit Survey
(3.4%)

14,335 Eligible Intervention Patients (96.6%)

16,380 Potentially Eligible Control Patients
(52.5%)
513 Ineligible at
Contact for PreVisit Survey
(3.1%)

15,867 Eligible Control Patients (96.9%)

8,474 Never
Reached
(59.1%)

9,808 Never
Reached
(61.8%)

3,162 Declined
Participation
(22.1%)

2,683 Declined
Participation
(16.9%)

2,699 Completed Pre-Visit Survey
(18.8%)
136 Ineligible at
Contact for
Post-Visit
Survey
(5.0%)
2,563 Eligible Intervention Patients (95.0%)
Completed Pre-Visit Survey

3,376 Completed Pre-Visit Survey
(21.3%)
220 Ineligible at
Contact for
Post-Visit
Survey
(6.5%)
3,156 Eligible Control Patients (93.5%)
Completed Pre-Visit Survey

857 Lost to
Follow Up
(33.4%)

1,143 Lost to
Follow Up
(36.2%)

7 Declined
Participation
(0.30%)

9 Declined
Participation
(0.3%)

1,699 Completed Post-Visit Survey with Outcome
Assessment and Included in Analysis (66.3%)

2,004 Completed Post-Visit Survey with Outcome
Assessment and Included in Analysis (63.5%)
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